INTERSECT ENT INC's ticker is XENT and the CUSIP is 46071F103. A total of 123 filers reported holding INTERSECT ENT INC in Q4 2021. The put-call ratio across all filers is 6.85 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $20,808,000 | +22.6% | 742,905 | +19.5% | 0.00% | +33.3% |
| Q4 2021 | $16,979,000 | +42.6% | 621,711 | +42.1% | 0.00% | 0.0% |
| Q3 2021 | $11,903,000 | +323.9% | 437,624 | +166.4% | 0.00% | +200.0% |
| Q2 2021 | $2,808,000 | -36.8% | 164,277 | -22.8% | 0.00% | 0.0% |
| Q1 2021 | $4,445,000 | -2.5% | 212,897 | +7.0% | 0.00% | 0.0% |
| Q4 2020 | $4,558,000 | +33.3% | 199,019 | -5.1% | 0.00% | 0.0% |
| Q3 2020 | $3,420,000 | +8.8% | 209,689 | -9.7% | 0.00% | 0.0% |
| Q2 2020 | $3,143,000 | -33.6% | 232,192 | -41.9% | 0.00% | -50.0% |
| Q1 2020 | $4,737,000 | -63.5% | 399,774 | -23.4% | 0.00% | -33.3% |
| Q4 2019 | $12,991,000 | +97.9% | 521,724 | +35.2% | 0.00% | +50.0% |
| Q3 2019 | $6,566,000 | -26.8% | 386,006 | -2.0% | 0.00% | -33.3% |
| Q2 2019 | $8,968,000 | +115.6% | 394,021 | +204.5% | 0.00% | +200.0% |
| Q1 2019 | $4,160,000 | -22.6% | 129,413 | -32.2% | 0.00% | -50.0% |
| Q4 2018 | $5,376,000 | -21.3% | 190,744 | -19.8% | 0.00% | 0.0% |
| Q3 2018 | $6,835,000 | -21.5% | 237,741 | +2.3% | 0.00% | 0.0% |
| Q2 2018 | $8,706,000 | +181.6% | 232,468 | +195.5% | 0.00% | +100.0% |
| Q1 2018 | $3,092,000 | +97.1% | 78,669 | +62.5% | 0.00% | – |
| Q4 2017 | $1,569,000 | -44.2% | 48,424 | -46.3% | 0.00% | -100.0% |
| Q3 2017 | $2,810,000 | -58.8% | 90,236 | -63.0% | 0.00% | -50.0% |
| Q2 2017 | $6,813,000 | +129.8% | 243,699 | +41.0% | 0.00% | – |
| Q1 2017 | $2,965,000 | +33.1% | 172,883 | -6.1% | 0.00% | – |
| Q4 2016 | $2,228,000 | -37.9% | 184,124 | -18.7% | 0.00% | -100.0% |
| Q3 2016 | $3,587,000 | +29.3% | 226,456 | +5.6% | 0.00% | 0.0% |
| Q2 2016 | $2,774,000 | -24.7% | 214,535 | +31.1% | 0.00% | – |
| Q4 2015 | $3,682,000 | +733.0% | 163,665 | +855.8% | 0.00% | – |
| Q1 2015 | $442,000 | -42.9% | 17,123 | -58.9% | 0.00% | – |
| Q4 2014 | $774,000 | +2.7% | 41,700 | -14.3% | 0.00% | – |
| Q3 2014 | $754,000 | – | 48,671 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| KOPP INVESTMENT ADVISORS LLC | 186,561 | $5,364,000 | 4.51% |
| First Light Asset Management, LLC | 517,121 | $14,867,000 | 2.40% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,147,950 | $61,754,000 | 2.21% |
| HealthCor Management, L.P. | 1,950,000 | $56,063,000 | 1.86% |
| PURA VIDA INVESTMENTS, LLC | 200,000 | $5,750,000 | 1.21% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 112,000 | $2,469,000 | 1.17% |
| Broadfin Capital, LLC | 234,200 | $6,733,000 | 0.99% |
| Lombard Odier Asset Management (USA) Corp | 240,000 | $6,900,000 | 0.51% |
| PURA VIDA INVESTMENTS, LLC | 83,527 | $2,401,000 | 0.50% |
| Rock Springs Capital Management LP | 460,000 | $13,225,000 | 0.48% |